A study found little clinical evidence supporting claims of popular over-the-counter supplements, with two (Relief Factor and Nugenix's Total-T and Free T) having no clinical research. None had strong independent, patient-oriented clinical outcome data. The U.S. supplement industry, valued at over $53 billion in 2023, operates under regulations that do not require the same level of testing as prescription products.